A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer
A Prospective Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Listed as NCT03756077, this observational or N/A phase trial focuses on PET/CT and PET/MR and remains ongoing. Sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, it has been updated 11 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Aug 2025 — Sep 2025 [monthly]
Unknown
-
Mar 2025 — Aug 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
-
May 2022 — Mar 2023 [monthly]
Recruiting
-
Mar 2021 — May 2022 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
Dec 2018 — Oct 2020 [monthly]
Recruiting
First recorded
Apr 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
For direct contact, visit the study record on ClinicalTrials.gov .